274 related articles for article (PubMed ID: 28376844)
21. Supramolecular assemblies based on complexes of nonionic amphiphilic cyclodextrins and a meso-tetra(4-sulfonatophenyl)porphine tributyltin(IV) derivative: potential nanotherapeutics against melanoma.
Mazzaglia A; Bondì ML; Scala A; Zito F; Barbieri G; Crea F; Vianelli G; Mineo P; Fiore T; Pellerito C; Pellerito L; Costa MA
Biomacromolecules; 2013 Nov; 14(11):3820-9. PubMed ID: 24102383
[TBL] [Abstract][Full Text] [Related]
22. Targeting the human parasite Leishmania donovani: discovery of a new promising anti-infectious pharmacophore in 3-nitroimidazo[1,2-a]pyridine series.
Castera-Ducros C; Paloque L; Verhaeghe P; Casanova M; Cantelli C; Hutter S; Tanguy F; Laget M; Remusat V; Cohen A; Crozet MD; Rathelot P; Azas N; Vanelle P
Bioorg Med Chem; 2013 Nov; 21(22):7155-64. PubMed ID: 24080103
[TBL] [Abstract][Full Text] [Related]
23. Antileishmanial potential of fused 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiols: Synthesis, biological evaluations and computational studies.
Patil SR; Asrondkar A; Patil V; Sangshetti JN; Kalam Khan FA; Damale MG; Patil RH; Bobade AS; Shinde DB
Bioorg Med Chem Lett; 2017 Aug; 27(16):3845-3850. PubMed ID: 28693910
[TBL] [Abstract][Full Text] [Related]
24. Structure based medicinal chemistry-driven strategy to design substituted dihydropyrimidines as potential antileishmanial agents.
Rashid U; Sultana R; Shaheen N; Hassan SF; Yaqoob F; Ahmad MJ; Iftikhar F; Sultana N; Asghar S; Yasinzai M; Ansari FL; Qureshi NA
Eur J Med Chem; 2016 Jun; 115():230-44. PubMed ID: 27017551
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of novel 2,3-disubstituted quinoxaline derivatives as antileishmanial and antitrypanosomal agents.
Cogo J; Kaplum V; Sangi DP; Ueda-Nakamura T; Corrêa AG; Nakamura CV
Eur J Med Chem; 2015 Jan; 90():107-23. PubMed ID: 25461316
[TBL] [Abstract][Full Text] [Related]
26. Antileishmanial activities of dihydrochalcones from piper elongatum and synthetic related compounds. Structural requirements for activity.
Hermoso A; Jiménez IA; Mamani ZA; Bazzocchi IL; Piñero JE; Ravelo AG; Valladares B
Bioorg Med Chem; 2003 Sep; 11(18):3975-80. PubMed ID: 12927858
[TBL] [Abstract][Full Text] [Related]
27. Antileishmanial activity of novel indolyl-coumarin hybrids: Design, synthesis, biological evaluation, molecular docking study and in silico ADME prediction.
Sangshetti JN; Kalam Khan FA; Kulkarni AA; Patil RH; Pachpinde AM; Lohar KS; Shinde DB
Bioorg Med Chem Lett; 2016 Feb; 26(3):829-835. PubMed ID: 26778149
[TBL] [Abstract][Full Text] [Related]
28. Clofazimine analogs with antileishmanial and antiplasmodial activity.
Barteselli A; Casagrande M; Basilico N; Parapini S; Rusconi CM; Tonelli M; Boido V; Taramelli D; Sparatore F; Sparatore A
Bioorg Med Chem; 2015 Jan; 23(1):55-65. PubMed ID: 25497962
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and Evaluation of Antileishmanial and Cytotoxic Activity of Benzothiopyrane Derivatives.
Ortiz C; Echeverri F; Robledo S; Lanari D; Curini M; Quiñones W; Vargas E
Molecules; 2020 Feb; 25(4):. PubMed ID: 32059518
[TBL] [Abstract][Full Text] [Related]
30. Cynaroside inhibits Leishmania donovani UDP-galactopyranose mutase and induces reactive oxygen species to exert antileishmanial response.
Tabrez S; Rahman F; Ali R; Alouffi AS; Akand SK; Alshehri BM; Alshammari FA; Alam A; Alaidarous MA; Banawas S; Dukhyil AAB; Rub A
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33367614
[TBL] [Abstract][Full Text] [Related]
31. Miltefosine--discovery of the antileishmanial activity of phospholipid derivatives.
Croft SL; Engel J
Trans R Soc Trop Med Hyg; 2006 Dec; 100 Suppl 1():S4-8. PubMed ID: 16904717
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, antileishmanial and antitrypanosomal activities of N-substituted tetrahydro-β-carbolines.
Manda S; Khan SI; Jain SK; Mohammed S; Tekwani BL; Khan IA; Vishwakarma RA; Bharate SB
Bioorg Med Chem Lett; 2014 Aug; 24(15):3247-50. PubMed ID: 24980054
[TBL] [Abstract][Full Text] [Related]
33. Structure-based virtual screening, molecular docking, ADMET and molecular simulations to develop benzoxaborole analogs as potential inhibitor against Leishmania donovani trypanothione reductase.
Pandey RK; Kumbhar BV; Sundar S; Kunwar A; Prajapati VK
J Recept Signal Transduct Res; 2017 Feb; 37(1):60-70. PubMed ID: 27147242
[TBL] [Abstract][Full Text] [Related]
34. Withametelin: a biologically active withanolide in cancer, inflammation, pain and depression.
Baig MW; Nasir B; Waseem D; Majid M; Khan MZI; Haq IU
Saudi Pharm J; 2020 Dec; 28(12):1526-1537. PubMed ID: 33424246
[TBL] [Abstract][Full Text] [Related]
35. Insights about resveratrol analogs against trypanothione reductase of
da Silva AD; Dos Santos JA; Machado PA; Alves LA; Laque LC; de Souza VC; Coimbra ES; Capriles PVSZ
J Biomol Struct Dyn; 2019 Jul; 37(11):2960-2969. PubMed ID: 30058445
[TBL] [Abstract][Full Text] [Related]
36. Prospecting for cytotoxic and antiprotozoal 4-aryl-4H-chromenes and 10-aryldihydropyrano[2,3-f]chromenes.
Martin EF; Mbaveng AT; de Moraes MH; Kuete V; Biavatti MW; Steindel M; Efferth T; Sandjo LP
Arch Pharm (Weinheim); 2018 Oct; 351(10):e1800100. PubMed ID: 30137687
[TBL] [Abstract][Full Text] [Related]
37. Discovery of a new antileishmanial hit in 8-nitroquinoline series.
Paloque L; Verhaeghe P; Casanova M; Castera-Ducros C; Dumètre A; Mbatchi L; Hutter S; Kraiem-M'rabet M; Laget M; Remusat V; Rault S; Rathelot P; Azas N; Vanelle P
Eur J Med Chem; 2012 Aug; 54():75-86. PubMed ID: 22608675
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of Novel Quaternary Ammonium Salts and Their in Vitro Antileishmanial Activity and U-937 Cell Cytotoxicity.
Duque-Benítez SM; Ríos-Vásquez LA; Ocampo-Cardona R; Cedeño DL; Jones MA; Vélez ID; Robledo SM
Molecules; 2016 Mar; 21(4):381. PubMed ID: 27043509
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and in vitro antileishmanial efficacy of novel benzothiadiazine-1,1-dioxide derivatives.
Mangwegape DK; Zuma NH; Aucamp J; N'Da DD
Arch Pharm (Weinheim); 2021 May; 354(5):e2000280. PubMed ID: 33491807
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, antileishmanial activity and cytotoxicity of 2,3-diaryl- and 2,3,8-trisubstituted imidazo[1,2-a]pyrazines.
Marchand P; Bazin MA; Pagniez F; Rivière G; Bodero L; Marhadour S; Nourrisson MR; Picot C; Ruchaud S; Bach S; Baratte B; Sauvain M; Pareja DC; Vaisberg AJ; Le Pape P
Eur J Med Chem; 2015 Oct; 103():381-95. PubMed ID: 26383125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
